{"name":"Celtic Pharma Development Services","slug":"celtic-pharma-development-services","ticker":"","exchange":"","domain":"","description":"Celtic Pharma Development Services is a specialized Contract Research Organization (CRO) dedicated to providing comprehensive clinical research and development services for pharmaceutical and biotechnology companies. With a focus on advancing drug candidates through clinical trials, the company has a robust pipeline of over 10 drugs in various stages of development, including several in Phase 3 trials.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"TDT067","genericName":"TDT067","slug":"tdt067","indication":"Relapsing forms of multiple sclerosis","status":"phase_3"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Transfersome","genericName":"Transfersome","slug":"transfersome","indication":"Other","status":"phase_3"}]}],"pipeline":[{"name":"TDT067","genericName":"TDT067","slug":"tdt067","phase":"phase_3","mechanism":"TDT067 is a small molecule that targets the S1P1 receptor.","indications":["Relapsing forms of multiple sclerosis"],"catalyst":""},{"name":"Transfersome","genericName":"Transfersome","slug":"transfersome","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQSy1ibmwyNWtIVnR0T18zaWI3STRFNGNiNzVrazQ1bjJvSFhHN2Fob0pLa3h2STVCRFRaVUZIOFhrbDhLSkFKRkU5UHFfZkdFcVlxc3VmUkRmaDYzZzBfd1dwWlhrSlE1TjQyendIdHZWSXM0dmNVVFc5RjBRckxCaHktcWdvNzVEbjhFYVUwZldfdWFseTUtY19sWE03bjlzQVlXYkMwd0dSRVA5bGc?oc=5","date":"2025-09-18","type":"pipeline","source":"PharmTech.com","summary":"CPHI Frankfurt Reveals 2025 Pharma Awards Finalists for Bio/Pharma Development - PharmTech.com","headline":"CPHI Frankfurt Reveals 2025 Pharma Awards Finalists for Bio/Pharma Development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxOSHBONk5CYXpTTHJvSURmLTZxX1ZzUEZoYmdKUUJidVFHZnB4MGtuSWVHb2lTMTRVMW9jVjB3X2Z0aW5ldDZKZWNvT3ZBek5VVnpYTHRSX2MtU2J0Q1RHdC1MN09ZX2pVNm1lZjNHbTRoUTRWNnFQRDN1dWZHTjJ4S1hQWWJfVUhrQUN3V1ZTb3lMUUhHeGJhSUg3U2tIUEtVUEYw?oc=5","date":"2025-09-18","type":"pipeline","source":"European Pharmaceutical Review","summary":"CPHI Pharma Awards 2025 finalists announced - European Pharmaceutical Review","headline":"CPHI Pharma Awards 2025 finalists announced","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgJBVV95cUxNTGRGMFpYa3dLOEstS1FtSFR3aGhDR1pwQVU4Z2ZXT1BYbFFsZV9zUWNMUEFNekdKMnVHZDZFR3dJMldnTjYzSHdRaEtBM2ROVTJXMDRCTVR1clBWWHV6U0lVUFhKeTB5Ykl2bUtKYkZydjNHMVFLdHR5Y0lHUjhhaC1YWlZWZkFuNnZ2bUV6Z0JoRG9TbmJYNXAtQUsza2hXNmRDbzBhWmtsZTlKV05tdFc5bDZWYkRJSklkLUFIR1kxbHJoTFRmeld5eURTYUtwVUJFZDZQN3hkb0oydFFRWnFMZVB2TkhUV2IySUtXcnBNQTBsVlFZT09SN1dwaHpPclUxdkRqb3VOQzlnZjBITUU5QXhuVkk1VUJoZmhoRmdXZGdDSWUtcFhB?oc=5","date":"2025-07-28","type":"pipeline","source":"Business Wire","summary":"ReAlta Life Sciences Strengthens Management Team with the Appointment of Biotechnology Business Leader Ellen Lubman, MBA as Chief Business Officer - Business Wire","headline":"ReAlta Life Sciences Strengthens Management Team with the Appointment of Biotechnology Business Leader Ellen Lubman, MBA","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxNSGtBVThhUGFJSWpGWW9qQURLVm02aFhxZjdUSEozaVo3VWdpYnpsaktYc2V2YTJQY2VMTWVWTWU0a2hPaEtWSFp1WnNPc3I2clNtOC1ySTBLTmZoU040X2ZFOHAxWTNLektMckZUb1R5c0V2azhLZ3dmNGVTR0tINzJYV0NvZmwxNzVHdmlSMkhJOHBvSGxvcnZ2MWZlcFFjNjJv?oc=5","date":"2025-07-18","type":"pipeline","source":"Think Business","summary":"Irish medtech start-ups to watch in 2026 - Think Business","headline":"Irish medtech start-ups to watch in 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNRFVnb01fcnVSLU1wLWNQLW1KMnRscmluOHB1V3J0N2dyXzVCOElDZVQ3bFFBUHpKWnZjSVNwbnoyel9YTXdKTGtraU5rYnRURDh4cE5LOERFUXkteEt0YldPSjhDN3UxV3R4bmRwOWZ6UHUzeG5VdFFuSnphR2RiVmlZVHNQV3lLeVRIY1VObEpzWXhWbFBoeXgyNUt1bGlreFREWXF5eW4?oc=5","date":"2023-08-07","type":"pipeline","source":"Silicon Republic","summary":"Celtic Biotech: Developing novel cancer treatments from snake venom - Silicon Republic","headline":"Celtic Biotech: Developing novel cancer treatments from snake venom","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1SZjNFeXlEMGNvZGVWZmo1QTBXXy1HSlB1OGl6UkJuUk5DU3Y3N1VDQXZjMHJfSm81RWwtcS1lTFI2UjN1VGk1dkFWdDI1bzl4QUEtVEMyWHp2Wkk3dGdQZlNoNWJpTTM1djdhYXFR?oc=5","date":"2021-02-09","type":"pipeline","source":"Irish Examiner","summary":"Wind energy can be as big as pharma in Cork Harbour, report claims - Irish Examiner","headline":"Wind energy can be as big as pharma in Cork Harbour, report claims","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxNaUdaX0c4Sl9iTm1JWkdXYUdJcktFTlduN1lPMnhTcVRKX1VUWmEzankzbjU5R1VHNVNIenFpLW9kMVNFdkM2VDFUOHVkeDF6dEJYWkJVZHJ3aWU5bzJmbmRrM3JUVEFWWm53eWYxWEV1QzI1VlhxcEFjbThrc2dBQnl0bDA?oc=5","date":"2019-04-12","type":"pipeline","source":"Cardiff University","summary":"‘Pharmabees’ to make honey cosmetics - Cardiff University","headline":"‘Pharmabees’ to make honey cosmetics","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":2},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}